QUOTE AND NEWS
Motley Fool  Nov 3  Comment 
Needham suspends clinical trial of buying Geron.
Market Intelligence Center  Oct 30  Comment 
Geron (NGM: GERN) opened at $6.04. So far today, the stock has hit a low of $5.86 and a high of $6.49. GERN is now trading at $6.05, up $0.28 (4.85%). The stock hit its 52-Week high of $9.24 in July and set its 52-Week low of $2.48 in November. ...
Business Wire  Oct 30  Comment 
Geron Corporation (Nasdaq: GERN) today announced the company’s plan to advance clinical development of its human embryonic stem cell (hESC)-based product, GRNOPC1, for the treatment of spinal cord injury. The plan is expected to enable Geron to
StreetInsider.com  Oct 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Geron+Corporation+%28GERN%29+Posts+Q3+EPS+of+%240.17%2C+Lower+than+Estimates/5056147.html for the full story.
StreetInsider.com  Oct 29  Comment 
Business Wire  Oct 29  Comment 
Geron Corporation (Nasdaq:GERN) today reported financial results for the three and nine months ended September 30, 2009. For the third quarter of 2009, the company reported net loss applicable to common stockholders of $15.2 million, or $(0.17) per
Business Wire  Oct 27  Comment 
Geron Corporation (NASDAQ:GERN) will announce its financial results for the 2009 third quarter on Thursday, October 29, 2009, after the closing of the equity market. Thomas B. Okarma, Ph.D., M.D., Geron’s president and chief executive officer, and
StreetInsider.com  Sep 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Geron+%28GERN%29+Sells+Stock%2C+Warrants+to+Institutional+Investors+for+Proceeds+of+%243.6M/4933374.html for the full story.
Business Wire  Sep 10  Comment 
Geron Corporation (Nasdaq:GERN) today announced that it has sold shares of Geron common stock and issued warrants to purchase common stock to institutional investors for proceeds of $3.6 million. The proceeds will fund an equity contribution to
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


You may also be interested in articles related to Geron (GERN):
 
GERN AT A GLANCE
P/E -9.73 
EV/EBITDA -11.9 
ROA -27.2%AVG
ROE -28.7%AVG
Debt to Equity 0.0540VERY LOW
Current Ratio 19.7VERY HIGH
Interest Coverage Ratio -445LOW
 
 
 
 
 
 
 
 



References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki